Matthew P. Mitchell, PharmD, MBA, FAMCP
Director, Pharmacy Services, SelectHealth, Murray, UTAuthored Items
RX Profiler: Review of Ribociclib for Advanced Hormone Receptor–Positive Breast Cancer
Based on the prevalence of invasive breast cancer, the amount of drug therapy required among a managed patient population is considerable, and significantly affects the top cancer trend therapies within the cancer budget for payers.
Last modified: June 25, 2018